Pharmacokinetic study of saquinavir hard gel caps/ritonavir in HIV-1-infected patients: 1600/100 mg once-daily compared with 2000/100 mg once-daily and 1000/100 mg twice-daily
Published inThe journal of antimicrobial chemotherapy, vol. 54, no. 4, p. 785-790
Publication date2004
Abstract
Keywords
- Adult
- Antiretroviral Therapy, Highly Active
- Capsules
- Drug Administration Schedule
- Female
- Gels
- HIV Infections/ drug therapy/metabolism
- HIV-1/ drug effects
- Humans
- Male
- Metabolic Clearance Rate
- Ritonavir/administration & dosage/ pharmacokinetics/therapeutic use
- Saquinavir/administration & dosage/ pharmacokinetics/therapeutic use
Affiliation entities
Citation (ISO format)
AUTAR, R. S. et al. Pharmacokinetic study of saquinavir hard gel caps/ritonavir in HIV-1-infected patients: 1600/100 mg once-daily compared with 2000/100 mg once-daily and 1000/100 mg twice-daily. In: The journal of antimicrobial chemotherapy, 2004, vol. 54, n° 4, p. 785–790. doi: 10.1093/jac/dkh415
Main files (1)
Article
Identifiers
- PID : unige:7089
- DOI : 10.1093/jac/dkh415
- PMID : 15329366
Additional URL for this publicationhttp://jac.oxfordjournals.org/cgi/reprint/54/4/785.pdf
Journal ISSN0305-7453